Synopsis
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992.Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on the OTUK Editorial Board; and Gianni Bonadonna, MD, of Istituto Nazionale Tumori.
Episodes
-
![Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision]()
Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision
15/06/2009 Duration: 07minAlso from the Palm Beach Cancer Symposium, Kathy Albain, MD, talks about the St. Gallen consensus meeting’s updated recommendations about adjuvant therapy for breast cancer—i.e., endorsing the 21-gene recurrence score and 70-gene profiling assay as key tools in decision-making for chemotherapy for ER-positive disease.
-
![The Smartest Oncologist in the World? – Well, at least in the US!]()
The Smartest Oncologist in the World? – Well, at least in the US!
01/06/2009 Duration: 06minStanley H. Winokur, MD, on his clever, fun, and ever-evolving one-minute daily Internet quiz that lets oncologists test their knowledge & compete against others. TheSmartestOncologist.com
-
![Cancer-Related Fatigue]()
Cancer-Related Fatigue
01/05/2009 Duration: 12minPaddy Stone of St. George's Hospital, University of London, & David Cella from Northwestern University Feinberg School of Medicine about the effective use of questionnaires for assessing, screening, and perhaps diagnosing cancer-related fatigue syndrome.
-
![Bilateral Prophylactic Mastectomy for DCIS]()
Bilateral Prophylactic Mastectomy for DCIS
01/04/2009 Duration: 10minTodd Tuttle from University of Minnesota & Abram Recht from Beth Israel Deaconess Medical Center on the surprisingly big recent increase in the use of prophylactic bilateral mastectomy for DCIS.
-
![10th European Congress on Perspectives in Lung Cancer, Brussels]()
10th European Congress on Perspectives in Lung Cancer, Brussels
06/03/2009 Duration: 07minSilvia Novello and Giorgio Scagliotti on harnessing insulin-like growth factor receptor inhibition in a Phase II study that showed clinical activity of figitumumab to be at least as good as that of inhibitors of other growth factors already being used in cancer.
-
![More from the ASH Annual Meeting!]()
More from the ASH Annual Meeting!
21/01/2009 Duration: 31minGreater Role for Umbilical Cord Blood in Adult Transplants (Mary Eapen, commentary from Armand Keating). Ex Vivo Expansion of Cord Blood Derived Progenitor Cells: Patient Transplant Data (Colleen Delaney, commentary from Armand Keating). Erythropoiesis-Stimulating Agents in Cancer Patients: Meta-Analysis Mortality Findings (Julia Bohlius, commentary from Linda Burns and George Canellos). Imatinib: Durable Responses and Survival in CML: 7-Year IRIS Results; Can Imatinib Be Stopped? (Stephen O'Brien).
-
![ASH Annual Meeting]()
ASH Annual Meeting
20/01/2009 Duration: 26minPeter Goodwin talks to key investigators Francesco Zaja (on rituximab for ITP); Hannes Wandt (on how platelet transfusions may be able to be withheld in certain patients receiving stem cell transplants for hematologic cancers); and Michael Hallek and Tadeusz Robak (on improved benefits for CLL patients with rituximab added to standard chemotherapy). Offering perspective are Kenneth Kaushansky, Linda Burns, and George Canellos.
-
![NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress]()
NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress
21/12/2008 Duration: 20minNew research for advanced NSCLC showing that combining monoclonal antibodies and chemotherapy can extend life: OTBN Editor Peter Goodwin and Producer Sarah Maxwell talk to Robert Pirker, Christian Manegold, Giorgio Scagliotti, Nick Thatcher, and Howard Sandler, MD. PLUS: Michel Coleman on the latest findings from the CONCORD study of international differences in survival rates for breast, prostate, and colorectal cancers.
